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Hodgkin lymphoma (HL) typically presents as nodal lesion and may involve extranodal sites during the progression
of the disease. Primary osseous HL without any lymph node association is extremely rare and only a few such cases
have been described in the literature. We present a case of unusual primary HL in rib occurring in a middle-aged
female patient. Computed tomography (CT) scan revealed an osteolytic lesion was located at the right second rib
and was associated with a large soft tissue mass. There was no regional lymph node involvement. CT scan of neck
and abdomen was performed and showed no pathologic findings, particularly no lymphadenopathy and
organomegaly could be observed. Histologically, typical binucleated Reed-Sternberg (RS) cells and lacunar cells
were scattered in the background of reactive inflammation with infiltration of lymphocytes, histiocytes and
eosinophilic granulocytes. By immunohistochemistry, RS cells and lacunar cells were positive for CD15 and CD30
with typical membrane and paranuclear dot-like staining pattern. However, these cells were negative for
Epstein-Barr virus detection by in situ hybridization. A diagnosis of primary osseous HL was made. The patient
received systemic chemotherapy and local radiotherapy, and was on regular follow-up for 24 months. There was no
sign of recurrence of tumor and lymph node or bone marrow involvement. Because there is a possibility of
secondary bone involvement by systemic HL, strict histological analysis and thorough radiographic examination are
suggested to be necessary for accurately diagnosing this tumor when it presents as a solitary bone lesion.
Virtual slides: The virtual slide(s) for this article can be found here:
http://www.diagnosticpathology.diagnomx.eu/vs/2846916171507084
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Hodgkin lymphoma (HL) most commonly occurs in cer-
vical lymph nodes, and the extranodal forms are rare
accounting for less than 1% [1-3]. Typically, HL is a sys-
temic disease in which 10% to 20% of cases show in-
volvement of the bone during the progression of the
disease [4-6]. However, primary osseous HL without
any lymph node association is extremely rare and so far
only a few such cases with immunohistochemical and/
or molecular confirmation have been described in the
literature, with none of these cases being from China
[7-20]. According to Ann Arbor classification, primary* Correspondence: lizhi@mail.sysu.edu.cn
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reproduction in any medium, provided the orextranodal HL is considered at stage I, but systemic HL
with secondary bone involvement corresponds to stage
IV of the disease. Therefore, it is indeed a challenge for
clinicians to make a correct diagnosis when the HL pre-
sents as a solitary bone mass because inaccurate diagno-
sis may lead to delays in clinical treatment. Herein we
describe an additional case of primary osseous HL aris-
ing in the rib in a middle-aged female patient without
any lymphatic manifestation.
Case presentation
Clinical presentation and management
A 38-year-old Chinese female presented with pain at the
right upper side of the chest and adjacent soft tissue
swelling for 3 months. A week before admission to our
hospital, she was suffering from a gradually severe painhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ferred to our hospital for examination and treatment.
Physical examination showed the patient had a mild soft
tissues edema at her right upper lateral chest wall and se-
vere pain was elicited upon chest pressure. The patient
had a low grade fever of 37.4°C. There was no weight loss
and no palpable lymphadenopathy or organomegaly. The
laboratory results, including blood count, differential,
liver and renal function, were within the normal range. A
computed tomography (CT) scan of the chest revealed a
single osteolytic lesion in the right second rib with asso-
ciated soft tissue mass, measuring 6.0 × 5.0 × 5.0 cm in
size. The most of rib was observed to be destroyed and
the involvement of adjacent pleura and right upper lobe
of lung were also noted (Figure 1). The lesion showed
moderate enhancement after gadolinium injection. There
was no enlarged lymph node found in mediastinum and
thoracic cavity. A CT scan of neck and abdomen showed
no pathologic findings, particularly no lymphadenopathy
could be observed. A CT guided needle biopsy was per-
formed initially, but histopathological examination
showed pieces of fibrosis with infiltration of inflamma-
tory cells. Therefore, a surgical biopsy followed by a
microscopic examination was performed. After diagnosis,
the patient underwent polychemotherapy according to a
modified COPP protocol (bleomycin, etoposide, adriamy-
cin, cyclophosphamide, vincristine, oncovin, procarba-
zine, prednisone) for five cycles before initiation of
involved field radiotherapy. The lesion was regressed,
and the patient was on regular follow-up for 24 months
after radiotherapy. The bone marrow examination was
performed at 6 months after radiotherapy, there was no
abnormality found. During the period of following-up,
there was no sign of recurrence of tumor and lymph
node enlargement.
Material and methods
The surgical biopsy was routinely fixed in 10% neutral
buffered formalin. The tissues were embedded in paraf-
fin. Four micrometer-thick sections were stained withFigure 1 Radiographic examination of the lesion. (a) Osteolytic lesion o
have a distinct border to the lung in periphery in computed tomography s
soft tissue extensions with moderate gadolinium enhancement but no invoH&E. Immunohistochemical analyses were performed
using the ChemMate Envision/HRP Kit (Dako, Glostrup,
Denmark). The antibodies used in this study included a
broad panel of antibodies against CD1a, CD3, CD4,
CD8, CD15, CD20, CD30, CD38, CD43, CD45,CD56,
CD79a, ALK, Pax-5, BOB-1, OCT-2, S-100 protein, pan-
cytokeratin and epithelial membrane antigen (EMA).
Epstein-Barr virus (EBV) infection was also assessed by
in situ hybridization for EBERs according to the manu-
facturer’s instruction (Dako, Glostrup, Denmark). The
antibodies were obtained from Dako Cytomation, Santa
Cruz Biotechnology (Santa Cruz, CA, USA) and Novo-
castra laboratories LTD (Hong Kong, China).
Results and discussion
Under microscopic examination, the lesions were charac-
terized by a fibrosis developing in bone marrow spaces,
which was infiltrated with diffuse lymphocytes, plasma
cells, histiocytes, and eosinophilic and neutrophilic gran-
ulocytes. Typical morphology of Reed-Sternberg (RS)
cells, with large cytoplasms and prominent eosinophilic
nucleoli, were scattered in the background of reactive in-
flammation. Lacunar cells, mummified cells and small
foci of acidophilic necrosis were also found in the tissue.
The immunohistochemistry staining of the RS popula-
tion confirmed the expression of PAX-5, CD30 and
CD15. However, these cells did not express CD1a, CD3,
CD4, CD8, CD20, CD38, CD43, CD45, CD56, CD79a,
ALK, BOB-1, OCT-2, S-100 protein, pan-cytokeratin and
EMA (Figure 2). Epstein-Barr virus (EBV) status was
negative. Taken together, these morphological and im-
munological data were consistent with a classical Hodg-
kin’s lymphoma, mixed cellularity, according to the
WHO diagnostic criteria [1].
Primary classical Hodgkin lymphomas (HLs) are well
established lymphoproliferative neoplasms of the lymph
nodes with bimodal age curve. The extranodal HLs are
rare and account for less than 1%. The most common
site of extranodal HLs is gastrointestinal tract, followed
by the pulmonary system, thyroid, skin, genitourinaryf the right second rib with associated soft tissue mass appeared to
can (white arrow). (b) The osseous destruction of rib showed adjacent
lvement of regional lymph node was observed.
Figure 2 Photomicrographs of the osseous lesion. (a) Scattered lacunar cells were observed in the inflammatory background with numerous
lymphocytes, histiocytes, and eosinophilic granulocytes. (b) Typical morphology of Reed-Sternberg cells, with large cytoplasms and prominent
eosinophilic nucleoli were also found in the lesion (white arrow). The immunohistochemical staining of the RS cells confirmed the expression of
CD30 (c) and CD15 (d) with typical membrane and paranuclear dot-like staining pattern (a-b, HE staining with original magnification × 400; c-d,
immunohistochemical staining with original magnification × 400).
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involvement could be observed in the late stages of HLs,
it is extremely rare for patients to present with primary
HLs of the bone. To our knowledge, so far primary osse-
ous HL has been reported in approximately 30 patients
in the literature. Some of the cases have been associated
with extra-osseous involvement. Primary osseous HL
confined to the bone is so rare that approximately 19
cases have been reported worldwide to date, only 12
patients with primary solitary osseous HL [7-14] and 7
patients with primary multifocal osseous HL disease
have been reported without lymphatic manifestations
[15-20]. Moreover, primary osseous HL presenting as a
bone lesion with an associated soft tissue mass is quite
unusual [10,21-23]. Histologically, mixed cellularity and
nodular sclerosis variant of classical HL are most com-
mon subtype of primary osseous HL in literature. In
clinical, four types of osseous involvement by HL may be
presented: (1) primary osseous HL with solitary lesion;
(2) primary osseous HL with multifocal lesion; (3) HL
simultaneously in osseous and non-osseous sites; and (4)
recurrence of HL at osseous sites.
Since cases of primary osseous HL are so rare, the
diagnosis should be only made by strict histological and
clinical manifestation. According to the WHO criteria, a
diagnosis of primary bone lymphoma must be (1) a sin-
gle skeletal tumor, with or without regional lymph node
involvement, and (2) multiple bone lesions without vis-
ceral or lymph node involvement [24]. Many previouslydescribed cases of primary extranodal HL appeared to
have concurrent and/or subsequent nodal involvement.
They are factually secondary cases in a context of sys-
temic HL. The word "primary" should be used cau-
tiously. In the present case, we found: (1) no superficial
lymphadenopathy presented at the time of diagnosis; (2)
chest, neck and abdomen radiological studies showed no
involvement of lymph nodes in mediastinum, thoracic
and abdominal cavity; (3) the complete blood count and
differential are within the normal limits; (4) the lesion
was predominant in bone with associated soft tissue
mass, without positive adjacent lymph nodes; (5) live,
spleen and bone marrow were free of disease at the time
of diagnosis and the period of following-up; (6) the RS
cells in tumor demonstrated a typical immunohisto-
chemical profile with CD30, CD15 and PAX-5 positive.
CD45, CD20 and other T-cell lineage markers were
negative. These results prove the present case to be of
primary osseous origin. The recent studies suggest that
2-[18 F]-fluoro-2-deoxy-D-glucose positron emission
tomography/computed tomography (18 F-FDG-PET/CT)
enables systemic HL with secondary bone invasion to
be distinguished from primitive osseous HL. This tech-
nique is highly specific in demonstrating the isolated
osseous localization of the tumor and should be recom-
mended in all patients with putative osseous lymphoma
[25].
Regarding the cellular origin of RS cells in HLs, espe-
cially for those in extranodal lesions, it remains to be
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lost their B cell phenotype due to destructive somatic
mutation [26]. Although recent investigations have
defined a characteristic profile of recurrent copy number
gains and losses in classical HL, including gains of chro-
mosomes 2p, 9p, 16p, and 17q and losses of 13q, 6q, and
11q, cytogenetic and molecular studies of HL are lim-
ited. Several recurrent genetic lesions have been identi-
fied in RS cells, and most of them affect members of the
JAK/STAT or NF-κB signaling pathways [27]. It is likely
that EBV plays a role in reprogramming and survival
through dysregulation of several signaling networks and
transcription factors, including inactivating mutations in
the TNFAIP3 tumor suppressor gene and encoding a
negative regulator of NF-κB activity [28]. The RS cell
furthers its own survival by attracting a supportive
microenvironment of immune and stromal cells, and
suppressing local immune responsiveness. Although
many questions remain unanswered, a better under-
standing of cellular interaction may help to clarify the
pathogenesis of HL and promote novel approaches for
targeting the therapy of this malignant tumor.
Osseous HLs usually show osteolysis in radiological
examination, it is often misdiagnosed as osteomyelitis
[10,16,29]. The present case exhibited either osteolytic
lesion with soft tissue mass or inflammatory background
with eosinophilic granulocytes infiltration, which might
sometimes cause diagnostic confusion with primary
bone sarcoma, eosinophilic granuloma and non-Hodgkin
lymphoma of bone. However, osteomyelitis and primary
bone sarcoma lack the specific RS cell with immunor-
eactivity for CD30 and CD15. Eosinophilic granuloma of
bone shows clonal neoplastic proliferation of Langerhans
cells that express CD1a, S-100 and Langerin. The inci-
dence of non-Hodgkin lymphoma of bone is higher than
that of primary osseous HL. The most common subtype
of non-Hodgkin lymphoma in bone is diffuse large
B-cell lymphoma. Immunohistochemically, most of non-
Hodgkin lymphomas of bone are positive for CD45 and
B-cell or T-cell lineage markers with or without CD30
expression. Co-expression of CD15 and CD30, but lack-
ing CD45 expression of tumor cells may be helpful to
confirm the diagnosis of osseous HL. Although the de-
tection of EBV-encoded RNA (EBER) or LMP1 is indica-
tive of classical HL, EBV is found in only a proportion of
cases, particularly in mixed cellularity and lymphocyte
depleted classical HL with the highest frequency of 75%
[1]. By contraries, some subtypes of non-Hodgkin
lymphoma, including extranodal NK/T cell lymphoma
and EBV positive diffuse large B-cell lymphoma, show
EBV infection in tumor cells. The present case showed
EBV negative by in situ hybridization although it pre-
sented typical histological and immunohistochemical
profile of classical HL. Therefore, detection of EBV-encoded products in tumor is not a definitive point to
confirm the diagnosis of HL. In addition, classical HL
has to be distinguished from anaplastic large cell lymph-
oma (ALCL) in such an unusual extranodal location be-
cause both tumors show CD30 immunoreactivity with
typical membrane and paranuclear dot-like staining pat-
tern [30]. However, differential diagnosis between HL
and ALCL can be made by expression of anaplastic
lymphoma kinase (ALK), EMA and CD45 which are typ-
ical of ALCL, ALK-positive, while co-expression of
CD30 and PAX5 is very helpful in differentiating HL
from ALCL, ALK-negative.
Conclusion
In conclusion, only a few cases of primary osseous HL
have been reported in the literature. Our additive case is
also presented for its rarity of site. It is the first case of pri-
mary osseous HL occurring in Chinese. The diagnosis of
primary osseous HL is difficult and should be made cau-
tiously. Besides confirmation by strict histopathological
and immunohistochemical analysis, radiographic examin-
ation is helpful for demonstrating potential extra-osseous
lesion to distinguish systemic HL with secondary bone in-
vasion from primary osseous HL. In clinical, an immediate
diagnosis at the early stage of disease and timely treatment
with systemic chemotherapy and local radiotherapy are
required because the patients with primary osseous HL
appear to have a good long-term prognosis when the le-
sion is restricted in bone without systemic dissemination.
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